Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$12.92 -0.29 (-2.20%)
As of: Oct 2, 2026 · 11:37 AM EDT

Arcturus Therapeutics Holdings (ARCT) Non-Current Deffered Revenue (2018 - 2025)

Updated

Arcturus Therapeutics Holdings (ARCT) recorded Non-Current Deffered Revenue of $4.22 million in Q3 2025, down 68.4% from $13.34 million a year earlier and down 51.9% from the prior quarter.

Analysis

Arcturus Therapeutics Holdings (ARCT) Non-Current Deffered Revenue (2018 - 2025) Analysis & Trends

At the end of FY2024, Arcturus Therapeutics Holdings reported Non-Current Deffered Revenue of $12.6 million, down 70.3% from FY2023.

  • Annual Non-Current Deffered Revenue has a five-year compound annual growth rate of -3.7% (FY2019 to FY2024).
  • Across earlier years, Non-Current Deffered Revenue came in at $42.5 million in FY2023 (+111.7%), $20.07 million in FY2022 (+0.7%), $19.93 million in FY2021 (+59.3%) and $12.51 million in FY2020 (-17.6%).
  • The Q3 2025 figure is the lowest quarterly Non-Current Deffered Revenue in data going back to Q4 2018.
  • On a year-over-year basis, Non-Current Deffered Revenue has declined for seven consecutive quarters, with an average decline of 29.3% over the last eight quarters.
  • Peak year-over-year performance for Non-Current Deffered Revenue in the last five years was growth of 709.2% in Q3 2023, against a decline of 70.3% in Q4 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $8.77 million (Q2 2025), $9.63 million (Q1 2025) and $12.6 million (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Arcturus Therapeutics Holdings 389.11 Mn -425.02 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 4.22 Mn
Jun 30, 2025 8.77 Mn
Mar 31, 2025 9.63 Mn
Dec 31, 2024 12.60 Mn
Sep 30, 2024 13.34 Mn
Jun 30, 2024 11.34 Mn
Mar 31, 2024 11.80 Mn
Dec 31, 2023 42.50 Mn
Sep 30, 2023 41.91 Mn
Jun 30, 2023 25.73 Mn
Mar 31, 2023 20.57 Mn
Dec 31, 2022 20.07 Mn
Sep 30, 2022 5.18 Mn
Jun 30, 2022 5.59 Mn
Mar 31, 2022 6.64 Mn
Dec 31, 2021 19.93 Mn
Sep 30, 2021 8.50 Mn
Jun 30, 2021 9.85 Mn
Mar 31, 2021 11.31 Mn
Dec 31, 2020 12.51 Mn
API Access

Arcturus Therapeutics Holdings Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ARCT&period=max&api_key=YOUR_API_KEY